ICU Medical (ICUI) Tops Q2 EPS by 46c ; Offers Guidance

ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $2.37, $0.46 better than the analyst estimate of $1.91. Revenue for the quarter came in at $551.68 million versus the consensus estimate of $533.3 million.

Outlook:-

FY 2026 EPS between $8.60 to $9.00 vs consensus $8.16.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c